Ptc Therapeutics Inc (PTCT)

SG&A Expenses

$351.33M

TTM · Period ending: · USD

PTCT logo

PTCT SG&A Expenses

Latest reported$351.33M
PTCT TTM SG&A Expenses ($14.62M → $351.33M)
High-resolution chart · PNG

PTCT sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ptc Therapeutics Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
351,333,000
355,965,000
350,743,000
334,952,000
324,362,000
308,600,000
300,911,000
292,519,000
299,949,000
318,898,000
332,540,000
348,967,000
348,199,000
339,642,000
325,999,000
319,829,000
308,963,000
297,949,000
285,773,000
274,681,000
263,269,000
248,050,000
245,164,000
233,205,000
224,649,000
220,205,000
202,540,000
187,709,000
176,793,000
161,123,000
153,548,000
140,364,000
133,419,000
128,740,000
121,271,000
109,961,000
102,192,000
96,692,000
97,130,000
98,845,000
96,559,000
90,403,000
82,080,000
74,210,000
63,372,000
54,895,000
44,820,000
34,286,358
30,435,350
28,297,407
25,218,652
20,959,732
18,064,669
14,633,997
14,615,376
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.